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care, and suicide. Premature mortality of patients with SCZ has been reported to 93 be 3.5 times (Olfson et al., 2015) greater than that of adults in the general 94 population. The societal costs of SCZ during a 12-month period have been 95 estimated to be as high as $890 million in the United States (Evensen et al., 96 2015) . All domains of quality of life (QoL; physical, psychological, and social) are 97 severely decreased in SCZ compared to healthy controls. QoL is also increasingly 98 becoming an important index for effectiveness of treatment in SCZ (Kane et al., 99 2016 Yamauchi et al., 2008) . However, a 106 comprehensive large-scale study using in-depth phenotyping to investigate 107 factors associated with QoL in SCZ in a hypothesis-generating fashion is lacking. 108
In addition, to the best of our knowledge, the genetic underpinnings of QoL have 109 not been investigated. Recently published genome-wide association studies 110 (GWASs) for SCZ (Ripke et al., 2014) and related traits such as major depressive 111 disorder (MDD) (Wray et al., 2018) (Korver et al., 2012) . 153
Psychosis-related and demographic variables that were included in the analysis 154 are presented in Appendix 1 (Supplemental Methods). These variables may be 155 divided into symptoms and experiences that were assessed with a range of 156 (semi)-structured scales (including drug use); family loading for psychiatric 157 disorders; social cognition; demographic variables; IQ; medication use data; and 158 theory of mind scales. For the purpose of the current study, we only used the 159 baseline assessments of the GROUP study (release 5.00) as we were interested in 160 factors contributing to QoL in SCZ apparent in its early disease stages (the first 161 psychotic episode of the GROUP participating patients had to occur within 10 162 years before this first assessment). Supplementary Figure 1 and study site were then used to test the association of QoL with each of the 184 clinical phenotypes. The statistical significance threshold for this association 185 analysis was corrected for multiple testing using the Bonferroni-correction 186 method, i.e. 4.76×10 -04 (0.05 adjusted for 105 independent tests) (Shaffer, 1995) . 187
The variance in QoL explained by the phenotypes was calculated using R square 188 values obtained from GLM. To then identify a set of variables that were 189 associated with QoL independent of one another, we used the phenotypes that 190 were associated with QoL at P<4.76×10 -04 and selected the independent 191 variables in a backward stepwise regression model. As a sensitivity analysis, we 192 then regressed the most significantly associated phenotypes with ordinal 193 estimates of QoL as opposed to the first principal component of QoL. Table 1 shows baseline characteristics of patients, relatives and controls. In the 266 generalized linear model (GLM), 18 distinct variables were associated with QoL 267 at the Bonferroni significance threshold of 4.76×10 -04 in schizophrenia patients 268 (Figure 1, Table 2 & Supplemental Results, Supplementary Figure 3) Figure 4) . 284
The variance in QoL explained by various PRSs (N=2,265) were 1.37% for SCZ, 285 1.37% for subjective wellbeing (Figure 2) Moreover, only SCZ and subjective wellbeing PRSs were consistent with true 306 polygenicity explaining a proportion of the variance in QoL, as may be 307 appreciated by increasing degrees of explained variances and increasing 308 significance levels with relaxing Pts (Figure 2) . Several of the variables we found to be associated with QoL in SCZ had to 336 the best of our knowledge not been reported, such as disorganization, obsessive 337 compulsive symptoms, suicidal attempts, unmet needs, acathisia, and cannabis 338 craving. Although the underlying mechanisms of this latter association are still 339 unclear, one may speculate that cannabis craving constitutes a proxy for 340 cannabis abstinence, which in turn may increase anxiety and thus reduce 341 psychological wellbeing. Alternatively, relatively high levels of cannabis 342 dependence may worsen symptoms and thus negatively impact QoL. 343
Genetic predisposition to SCZ captured by PRS showed clear and persistent 344 effects on QoL across all Pts. We also observed moderate effects of polygenic 345 susceptibility to subjective well-being on QoL and no independent effects of 346 genetic predisposition to MDD on QoL in our cohort. 347
The current study benefits from a large sample size of a multicenter prospective 348 cohort study in the Netherlands with comprehensive phenotypic assessments in Figure 3) . Second, we are aware of relatively low power for 362 genetic studies on a complex trait such as QoL both in our GWAS and LD score 363 regression analyses. Our GWAS must therefore be regarded as a first exploratory 364 GWAS of QoL in SCZ subjects, their siblings and healthy controls. Similarly, for LD 365 score regression (LDSC), we were underpowered to reveal clear genetic 366 correlations. LDSC analysis was done to explore possible genetic correlations 367 with traits different from the ones we investigated and to investigate whether 368 the trait with most significant genetic correlation results was identical to the 369 trait with most significant PRS results, which indeed turned out to be the case. 370
Third, in the current study population about 97% of participants were 371
Caucasians which hampers generalizability to other ethnicities. Finally, our 372 association analyses preclude us from drawing definite conclusions about 373 causality. Future, well powered, prospective studies are necessary to improve 374 insight into possible causal mechanisms. 375
In conclusion, we highlight multiple clinical and genetic associations with QoL 376 that could be leveraged in daily care of patients with SCZ to improve their QoL. 377
The variables highlighted in the current study could aid health professionals who 378 interact with psychotic patients to more readily recognize the need for additional 
